Global Viral Clearance Market was valued US$205.0 Mn in 2017 and is estimated to reach US$915.0 Mn by 2026 at a CAGR of 20.56%.
Global viral clearance market has drivers that, rapid growth in pharmaceutical and biotechnology industries. The strong trend of R&D in the life sciences industry. The increasing number of the new drug. Increasing government initiatives. Restrain of viral clearance market is the High degree of consolidation to act. Trends and future prospects for the market are also included in the report which gives an intellectual understanding of the viral clearance industry.
Viral clearance market is segmented by a method, application, end user, and region. Based on method, viral clearance market is classified into viral detection method, viral inactivation method, and viral removal method. Viral removal method is expected to hold the largest market in forecast period due to rising biopharmaceutical R&D activities.
In terms of an end user, viral clearance market is divided by pharmaceutical & biotechnology companies, CROs, academic research institutes, and others. Pharmaceutical & biotechnology companies are expected to share the largest market of viral clearance during the forecast period.
On the basis of application, viral clearance market is segmented by recombinant proteins, blood and blood products, vaccines, and others. Recombinant proteins are estimated to holds largest share of a market in forecast period due to it has huge potential to treat various diseases, tiny side effects, and it takes less time for the development.
In terms of region, Asia Pacific is expected to witness the highest growth from 2018 to 2026, owing to increase in generics development and manufacturing, surge in Chinese funding for medical research, and presence of large number of CROs to provide preclinical and clinical research services in China, government initiatives to boost the use of generic drugs, increasing aging population in Japan, rise in pharmaceutical R&D expenditures in India, and the growing pharmaceutical manufacturing in Singapore and Malaysia.
Key players operate on, Charles River Laboratories International Inc., Merck KGaA, Wuxi Biologics, Kedrion S.p.A., Vironova Biosafety, Texcell, Clean Cells, BSL BIOSERVICE Scientific Laboratories Munich GmbH, ViruSure GmbH, Lonza group, Sigma-Aldrich Corporation, SGS S.A, Avance Biosciences Inc
The scope of Report Global Viral Clearance Market:
Global Viral Clearance Market, by Method:
Viral detection method
Viral inactivation method
Viral removal method
Global Viral Clearance Market, by Application:
Recombinant proteins
Blood and blood products
Vaccines
Others
Global Viral Clearance Market, by End User:
Pharmaceutical & biotechnology companies
Cros
Academic research institutes
Others
Global Viral Clearance Market, by Region:
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Key Players, Global Viral Clearance Market:
Charles River Laboratories International Inc.
Merck KGaA
Wuxi Biologics
Kedrion S.p.A.
Vironova Biosafety
Texcell
Clean Cells
BSL BIOSERVICE Scientific Laboratories Munich GmbH
ViruSure GmbH
Lonza group
Sigma-Aldrich Corporation
SGS S.A
Avance Biosciences Inc
Global Viral Clearance Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
1.4. Key Questions Answered
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Viral Clearance Market Size, by Market Value (US$ Mn) and Market, by Region
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Porter’s Analysis
4.3.5. Value Chain Analysis
4.3.6. SWOT Analysis
4.4. <a href="https://www.maximizemarketresearch.com/MMR/industry-trends/key-trends-in-global-viral-clearance-market/155/">Global Viral Clearance Market Industry Trends</a> and Emerging Technologies
5. Global Viral Clearance Market Analysis and Forecast
5.1. Global Viral Clearance Market Analysis and Forecast
5.2. Global Viral Clearance Market Size& Y-o-Y Growth Analysis
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Middle East & Africa
5.2.5. Latin America
6. Global Viral Clearance Market Analysis and Forecast, by Method
6.1. Introduction and Definition
6.2. Key Findings
6.3. Global Viral Clearance Market Value Share Analysis, by Method
6.4. Market Size (US$ Mn) Forecast, by Method
6.5. Global Viral Clearance Market Analysis, by Method
6.6. Viral Clearance Market Attractiveness Analysis, by Method
7. Global Viral Clearance Market Analysis and Forecast, by Application
7.1. Introduction and Definition
7.2. Global Viral Clearance Market Value Share Analysis, by Application
7.3. Market Size (US$ Mn) Forecast, by Application
7.4. Global Viral Clearance Market Analysis, by Application
7.5. Global Viral Clearance Market Attractiveness Analysis, by Application
8. Global Viral Clearance Market Analysis and Forecast, by End User
8.1. Introduction and Definition
8.2. Global Viral Clearance Market Value Share Analysis, by End User
8.3. Market Size (US$ Mn) Forecast, by End User
8.4. Global Viral Clearance Market Analysis, by End User
8.5. Global Viral Clearance Market Attractiveness Analysis, by End User
9. Global Viral Clearance Market Analysis, by Region
9.1. Global Viral Clearance Market Value Share Analysis, by Region
9.2. Market Size (US$ Mn) Forecast, by Region
9.3. Global Viral Clearance Market Attractiveness Analysis, by Region
10. North America Viral Clearance Market Analysis
10.1. Key Findings
10.2. North America Viral Clearance Market Overview
10.3. North America Viral Clearance Market Value Share Analysis, by Method
10.4. North America Viral Clearance Market Forecast, by Method
10.4.1. Viral detection method
10.4.2. Viral inactivation method
10.4.3. Viral removal method
10.5. North America Viral Clearance Market Value Share Analysis, by Application
10.6. North America Viral Clearance Market Forecast, by Application
10.6.1. Recombinant proteins
10.6.2. Blood and blood products
10.6.3. Vaccines
10.6.4. Others
10.7. North America Viral Clearance Market Value Share Analysis, by End User
10.8. North America Viral Clearance Market Forecast, by End User
10.8.1. Pharmaceutical & biotechnology companies
10.8.2. Cros
10.8.3. Academic research institutes
10.8.4. Others
10.9. North America Viral Clearance Market Value Share Analysis, by Country
10.10. North America Viral Clearance Market Forecast, by Country
10.10.1. U.S.
10.10.2. Canada
10.11. North America Viral Clearance Market Analysis, by Country
10.12. U.S. Viral Clearance Market Forecast, by Method
10.12.1. Viral detection method
10.12.2. Viral inactivation method
10.12.3. Viral removal method
10.13. U.S. Viral Clearance Market Forecast, by Application
10.13.1. Recombinant proteins
10.13.2. Blood and blood products
10.13.3. Vaccines
10.13.4. Others
10.14. U.S. Viral Clearance Market Forecast, by End User
10.14.1. Pharmaceutical & biotechnology companies
10.14.2. Cros
10.14.3. Academic research institutes
10.14.4. Others
10.15. Canada Viral Clearance Market Forecast, by Method
10.15.1. Predictive maintenance and machinery inspection
10.15.2. Viral detection method
10.15.3. Viral inactivation method
10.15.4. Viral removal method
10.16. Canada Viral Clearance Market Forecast, by Application
10.16.1. Recombinant proteins
10.16.2. Blood and blood products
10.16.3. Vaccines
10.16.4. Others
10.17. Canada Viral Clearance Market Forecast, by End User
10.17.1. Pharmaceutical & biotechnology companies
10.17.2. Cros
10.17.3. Academic research institutes
10.17.4. Others
10.18. North America Viral Clearance Market Attractiveness Analysis
10.18.1. By Method
10.18.2. By Application
10.18.3. By End User
10.19. PEST Analysis
11. Europe Viral Clearance Market Analysis
11.1. Key Findings
11.2. Europe Viral Clearance Market Overview
11.3. Europe Viral Clearance Market Value Share Analysis, by Method
11.4. Europe Viral Clearance Market Forecast, by Method
11.4.1. Viral detection method
11.4.2. Viral inactivation method
11.4.3. Viral removal method
11.5. Europe Viral Clearance Market Value Share Analysis, by Application
11.6. Europe Viral Clearance Market Forecast, by Application
11.6.1. Recombinant proteins
11.6.2. Blood and blood products
11.6.3. Vaccines
11.6.4. Others
11.7. Europe Viral Clearance Market Value Share Analysis, by End User
11.8. Europe Viral Clearance Market Forecast, by End User
11.8.1. Pharmaceutical & biotechnology companies
11.8.2. Cros
11.8.3. Academic research institutes
11.8.4. Others
11.9. Europe Viral Clearance Market Value Share Analysis, by Country
11.10. Europe Viral Clearance Market Forecast, by Country
11.10.1.1. Germany
11.10.1.2. U.K.
11.10.1.3. France
11.10.1.4. Italy
11.10.1.5. Spain
11.10.1.6. Rest of Europe
11.11. Europe Viral Clearance Market Analysis, by Country/ Sub-region
11.12. Germany Viral Clearance Market Forecast, by Method
11.12.1. Viral detection method
11.12.2. Viral inactivation method
11.12.3. Viral removal method
11.13. Germany Viral Clearance Market Forecast, by Application
11.13.1. Recombinant proteins
11.13.2. Blood and blood products
11.13.3. Vaccines
11.13.4. Others
11.14. Germany Viral Clearance Market Forecast, by End User
11.14.1. Pharmaceutical & biotechnology companies
11.14.2. Cros
11.14.3. Academic research institutes
11.14.4. Others
11.15. U.K. Viral Clearance Market Forecast, by Method
11.15.1. Viral detection method
11.15.2. Viral inactivation method
11.15.3. Viral removal method
11.16. U.K. Viral Clearance Market Forecast, by Application
11.16.1. Recombinant proteins
11.16.2. Blood and blood products
11.16.3. Vaccines
11.16.4. Others
11.17. U.K. Viral Clearance Market Forecast, by End User
11.17.1. Pharmaceutical & biotechnology companies
11.17.2. Cros
11.17.3. Academic research institutes
11.17.4. Others
11.18. France Viral Clearance Market Forecast, by Method
11.18.1. Viral detection method
11.18.2. Viral inactivation method
11.18.3. Viral removal method
11.19. France Viral Clearance Market Forecast, by Application
11.19.1. Recombinant proteins
11.19.2. Blood and blood products
11.19.3. Vaccines
11.19.4. Others
11.20. France Viral Clearance Market Forecast, by End User
11.20.1. Pharmaceutical & biotechnology companies
11.20.2. Cros
11.20.3. Academic research institutes
11.20.4. Others
11.21. Italy Viral Clearance Market Forecast, by Method
11.21.1. Viral detection method
11.21.2. Viral inactivation method
11.21.3. Viral removal method
11.22. Italy Viral Clearance Market Forecast, by Application
11.22.1. Recombinant proteins
11.22.2. Blood and blood products
11.22.3. Vaccines
11.22.4. Others
11.23. Italy Viral Clearance Market Forecast, by End User
11.23.1. Pharmaceutical & biotechnology companies
11.23.2. Cros
11.23.3. Academic research institutes
11.23.4. Others
11.24. Spain Viral Clearance Market Forecast, by Method
11.24.1. Viral detection method
11.24.2. Viral inactivation method
11.24.3. Viral removal method
11.25. Spain Viral Clearance Market Forecast, by Application
11.25.1. Recombinant proteins
11.25.2. Blood and blood products
11.25.3. Vaccines
11.25.4. Others
11.26. Spain Viral Clearance Market Forecast, by End User
11.26.1. Pharmaceutical & biotechnology companies
11.26.2. Cros
11.26.3. Academic research institutes
11.26.4. Others
11.27. Rest of Europe Viral Clearance Market Forecast, by Method
11.27.1. Viral detection method
11.27.2. Viral inactivation method
11.27.3. Viral removal method
11.28. Rest of Europe Viral Clearance Market Forecast, by Application
11.28.1. Recombinant proteins
11.28.2. Blood and blood products
11.28.3. Vaccines
11.28.4. Others
11.29. Rest of Europe Viral Clearance Market Forecast, by End User
11.29.1. Pharmaceutical & biotechnology companies
11.29.2. Cros
11.29.3. Academic research institutes
11.29.4. Others
11.30. Europe Viral Clearance Market Attractiveness Analysis
11.30.1. By Method
11.30.2. By Application
11.30.3. By End User
11.31. PEST Analysis
12. Asia Pacific Viral Clearance Market Analysis
12.1. Key Findings
12.2. Asia Pacific Viral Clearance Market Overview
12.3. Asia Pacific Viral Clearance Market Value Share Analysis, by Method
12.4. Asia Pacific Viral Clearance Market Forecast, by Method
12.4.1. Viral detection method
12.4.2. Viral inactivation method
12.4.3. Viral removal method
12.5. Asia Pacific Viral Clearance Market Value Share Analysis, by Application
12.6. Asia Pacific Viral Clearance Market Forecast, by Application
12.6.1. Recombinant proteins
12.6.2. Blood and blood products
12.6.3. Vaccines
12.6.4. Others
12.7. Asia Pacific Viral Clearance Market Value Share Analysis, by End User
12.8. Asia Pacific Viral Clearance Market Forecast, by End User
12.8.1. Pharmaceutical & biotechnology companies
12.8.2. Cros
12.8.3. Academic research institutes
12.8.4. Others
12.9. Asia Pacific Viral Clearance Market Value Share Analysis, by Country
12.10. Asia Pacific Viral Clearance Market Forecast, by Country
12.10.1. China
12.10.2. India
12.10.3. Japan
12.10.4. ASEAN
12.10.5. Rest of Asia Pacific
12.11. Asia Pacific Viral Clearance Market Analysis, by Country/ Sub-region
12.12. China Viral Clearance Market Forecast, by Method
12.12.1. Viral detection method
12.12.2. Viral inactivation method
12.12.3. Viral removal method
12.13. China Viral Clearance Market Forecast, by Application
12.13.1. Recombinant proteins
12.13.2. Blood and blood products
12.13.3. Vaccines
12.13.4. Others
12.14. China Viral Clearance Market Forecast, by End User
12.14.1. Pharmaceutical & biotechnology companies
12.14.2. Cros
12.14.3. Academic research institutes
12.14.4. Others
12.15. India Viral Clearance Market Forecast, by Method
12.15.1. Viral detection method
12.15.2. Viral inactivation method
12.15.3. Viral removal method
12.16. India Viral Clearance Market Forecast, by Application
12.16.1. Recombinant proteins
12.16.2. Blood and blood products
12.16.3. Vaccines
12.16.4. Others
12.17. India Viral Clearance Market Forecast, by End User
12.17.1. Pharmaceutical & biotechnology companies
12.17.2. Cros
12.17.3. Academic research institutes
12.17.4. Others
12.18. Japan Viral Clearance Market Forecast, by Method
12.18.1. Viral detection method
12.18.2. Viral inactivation method
12.18.3. Viral removal method
12.19. Japan Viral Clearance Market Forecast, by Application
12.19.1. Recombinant proteins
12.19.2. Blood and blood products
12.19.3. Vaccines
12.19.4. Others
12.20. Japan Viral Clearance Market Forecast, by End User
12.20.1. Pharmaceutical & biotechnology companies
12.20.2. Cros
12.20.3. Academic research institutes
12.20.4. Others
12.21. ASEAN Viral Clearance Market Forecast, by Method
12.21.1. Viral detection method
12.21.2. Viral inactivation method
12.21.3. Viral removal method
12.22. ASEAN Viral Clearance Market Forecast, by Application
12.22.1. Recombinant proteins
12.22.2. Blood and blood products
12.22.3. Vaccines
12.22.4. Others
12.23. ASEAN Viral Clearance Market Forecast, by End User
12.23.1. Pharmaceutical & biotechnology companies
12.23.2. Cros
12.23.3. Academic research institutes
12.23.4. Others
12.24. Rest of Asia Pacific Viral Clearance Market Forecast, by Method
12.24.1. Viral detection method
12.24.2. Viral inactivation method
12.24.3. Viral removal method
12.25. Rest of Asia Pacific Viral Clearance Market Forecast, by Application
12.25.1. Recombinant proteins
12.25.2. Blood and blood products
12.25.3. Vaccines
12.25.4. Others
12.26. Rest of Asia Pacific Viral Clearance Market Forecast, by End User
12.26.1. Pharmaceutical & biotechnology companies
12.26.2. Cros
12.26.3. Academic research institutes
12.26.4. Others
12.27. Asia Pacific Viral Clearance Market Attractiveness Analysis
12.27.1. By Method
12.27.2. By Application
12.27.3. By End User
12.28. PEST Analysis
13. Middle East & Africa Viral Clearance Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Viral Clearance Market Overview
13.3. Middle East & Africa Viral Clearance Market Value Share Analysis, by Method
13.4. Middle East & Africa Viral Clearance Market Forecast, by Method
13.4.1. Viral detection method
13.4.2. Viral inactivation method
13.4.3. Viral removal method
13.5. Middle East & Africa Viral Clearance Market Value Share Analysis, by Application
13.6. Middle East & Africa Viral Clearance Market Forecast, by Application
13.6.1. Recombinant proteins
13.6.2. Blood and blood products
13.6.3. Vaccines
13.6.4. Others
13.7. Middle East & Africa Viral Clearance Market Value Share Analysis, by End User
13.8. Middle East & Africa Viral Clearance Market Forecast, by End User
13.8.1. Pharmaceutical & biotechnology companies
13.8.2. Cros
13.8.3. Academic research institutes
13.8.4. Others
13.9. Middle East & Africa Viral Clearance Market Value Share Analysis, by Country
13.10. Middle East & Africa Viral Clearance Market Forecast, by Country
13.10.1. GCC
13.10.2. South Africa
13.10.3. Rest of Middle East & Africa
13.11. Middle East & Africa Viral Clearance Market Analysis, by Country/ Sub-region
13.12. GCC Viral Clearance Market Forecast, by Method
13.12.1. Viral detection method
13.12.2. Viral inactivation method
13.12.3. Viral removal method
13.13. GCC Viral Clearance Market Forecast, by Application
13.13.1. Recombinant proteins
13.13.2. Blood and blood products
13.13.3. Vaccines
13.13.4. Others
13.14. GCC Viral Clearance Market Forecast, by End User
13.14.1. Pharmaceutical & biotechnology companies
13.14.2. Cros
13.14.3. Academic research institutes
13.14.4. Others
13.15. South Africa Viral Clearance Market Forecast, by Method
13.15.1. Viral detection method
13.15.2. Viral inactivation method
13.15.3. Viral removal method
13.16. South Africa Viral Clearance Market Forecast, by Application
13.16.1. Recombinant proteins
13.16.2. Blood and blood products
13.16.3. Vaccines
13.16.4. Others
13.17. South Africa Viral Clearance Market Forecast, by End User
13.17.1. Pharmaceutical & biotechnology companies
13.17.2. Cros
13.17.3. Academic research institutes
13.17.4. Others
13.18. Rest of Middle East & Africa Viral Clearance Market Forecast, by Method
13.18.1. Viral detection method
13.18.2. Viral inactivation method
13.18.3. Viral removal method
13.19. Rest of Middle East & Africa Viral Clearance Market Forecast, by Application
13.19.1. Recombinant proteins
13.19.2. Blood and blood products
13.19.3. Vaccines
13.19.4. Others
13.20. Rest of Middle East & Africa Viral Clearance Market Forecast, by End User
13.20.1. Pharmaceutical & biotechnology companies
13.20.2. Cros
13.20.3. Academic research institutes
13.20.4. Others
13.21. Middle East & Africa Viral Clearance Market Attractiveness Analysis
13.21.1. By Method
13.21.2. By Application
13.21.3. By End User
13.22. PEST Analysis
14. Latin America Viral Clearance Market Analysis
14.1. Key Findings
14.2. Latin America Viral Clearance Market Overview
14.3. Latin America Viral Clearance Market Value Share Analysis, by Method
14.4. Latin America Viral Clearance Market Forecast, by Method
14.4.1. Viral detection method
14.4.2. Viral inactivation method
14.4.3. Viral removal method
14.5. Latin America Viral Clearance Market Value Share Analysis, by Application
14.6. Latin America Viral Clearance Market Forecast, by Application
14.6.1. Recombinant proteins
14.6.2. Blood and blood products
14.6.3. Vaccines
14.6.4. Others
14.7. Latin America Viral Clearance Market Value Share Analysis, by End User
14.8. Latin America Viral Clearance Market Forecast, by End User
14.8.1. Pharmaceutical & biotechnology companies
14.8.2. Cros
14.8.3. Academic research institutes
14.8.4. Others
14.9. Latin America Viral Clearance Market Value Share Analysis, by Country
14.10. Latin America Viral Clearance Market Forecast, by Country
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Latin America Viral Clearance Market Analysis, by Country/ Sub-region
14.12. Brazil Viral Clearance Market Forecast, by Method
14.12.1. Viral detection method
14.12.2. Viral inactivation method
14.12.3. Viral removal method
14.13. Brazil Viral Clearance Market Forecast, by Application
14.13.1. Recombinant proteins
14.13.2. Blood and blood products
14.13.3. Vaccines
14.13.4. Others
14.14. Brazil Viral Clearance Market Forecast, by End User
14.14.1. Pharmaceutical & biotechnology companies
14.14.2. Cros
14.14.3. Academic research institutes
14.14.4. Others
14.15. Mexico Viral Clearance Market Forecast, by Method
14.15.1. Viral detection method
14.15.2. Viral inactivation method
14.15.3. Viral removal method
14.16. Mexico Viral Clearance Market Forecast, by Application
14.16.1. Recombinant proteins
14.16.2. Blood and blood products
14.16.3. Vaccines
14.16.4. Others
14.17. Mexico Viral Clearance Market Forecast, by End User
14.17.1. Pharmaceutical & biotechnology companies
14.17.2. Cros
14.17.3. Academic research institutes
14.17.4. Others
14.18. Rest of Latin America Viral Clearance Market Forecast, by Method
14.18.1. Viral detection method
14.18.2. Viral inactivation method
14.18.3. Viral removal method
14.19. Rest of Latin America Viral Clearance Market Forecast, by Application
14.19.1. Recombinant proteins
14.19.2. Blood and blood products
14.19.3. Vaccines
14.19.4. Others
14.20. Rest of Latin America Viral Clearance Market Forecast, by End User
14.20.1. Pharmaceutical & biotechnology companies
14.20.2. Cros
14.20.3. Academic research institutes
14.20.4. Others
14.21. Latin America Viral Clearance Market Attractiveness Analysis
14.21.1. By Method
14.21.2. By Application
14.21.3. By End User
14.22. PEST Analysis
15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.3. Company Profiles: Key Players
15.3.1. Texcell
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Business Strategy
15.3.1.4. Recent Developments
15.3.1.5. Manufacturing Footprint
15.3.2. Charles River Laboratories International Inc.
15.3.3. Merck KGaA
15.3.4. Wuxi Biologics
15.3.5. Kedrion S.p.A.
15.3.6. Vironova Biosafety
15.3.7. Texcell
15.3.8. Clean Cells
15.3.9. BSL BIOSERVICE Scientific Laboratories Munich GmbH
15.3.10. ViruSure GmbH
15.3.11. Lonza group
15.3.12. Sigma-Aldrich Corporation
15.3.13. SGS S.A
15.3.14. Avance Biosciences Inc
16. Primary Key Insights
